Oxycodone Hydrochloride
Product Images NDC 0115-1561

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxycodone Hydrochloride (NDC 0115-1561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Oxycodone Hydrochloride Extended Release Tablets 1)

This is a graph displaying the percentage reduction in drug liking for Oxycodone HCI Extended-Release Tablets compared to powdered Oxycodone HCI after intranasal administration. The x-axis displays the varying doses, and the y-axis displays the percentage reduction in drug liking. There is no further information available in the given text.*

FDA Label Image

Chemical Structure (Oxycodone Hydrochloride Extended Release Tablets 2)

FDA Label Image

10 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 3)

This is a medication guide for Oxycodone Hydrochloride Extended-Release Tablets. The Attention Dispenser indicates that it must be accompanied by the guide. The NDC number is 0115-1556-01 and it is manufactured by Purdue Pharmaceuticals L.P. The tablets are only available through prescription and the package contains 100 tablets. The document also includes the contact information of the distributor, Amneal Pharmaceuticals LLC.*

FDA Label Image

15 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 4)

This is a prescription drug label for Oxycodone Hydrochloride Extended-Release Tablets. The label includes important details such as the NDC code (NDC0115-1557-01), the quantity (100 tablets), and the manufacturer (Purdue Pharmaceuticals L.P.). The label states that it is necessary to provide an accompanying medication guide to the patient. This guide is not available in the text.*

FDA Label Image

20 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 5)

This text appears to be a mix of information related to a medication named Oxycodone Hydrochloride, such as its dosage (225) and form (extended-release tablets), its NDC (National Drug Code) product code (0115-1558-01), as well as the name and location of its manufacturer (Purdue Pharmaceuticals, L.P in Wilson, NC) and distributor (Amneal Pharmaceuticals LLC). There is also a reference to a "Dispense & dication Guid" but the content or purpose of this guide is not clear.*

FDA Label Image

30 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 6)

This is a medication label for Oxycodone Hydrochloride Extended-Release Tablets. The label includes the NDC number, dosage amounts, manufacturer information, and medication guide requirements.*

FDA Label Image

40 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 7)

This is a medication guide for Oxycodone Hydrochloride Extended-Release Tablets that must be provided to the patient upon dispensing. It includes information about the medication and its dosage. The tablets are manufactured by Pure Pharmaceuticals and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

FDA Label Image

60 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 8)

FDA Label Image

80 mg Bottle Label (Oxycodone Hydrochloride Extended Release Tablets 9)

This text is a warning label for Oxycodone Hydrochloride Extended-Release Tablets. It cautions the reader to keep the drug out of reach of children and instructs the dispenser to provide the accompanying medication guide to the patient. It also provides the National Drug Code (NDC) for the medication and the name of the manufacturer and distributor. The text advises the patient to swallow the tablets whole and not to cut, break, chew or dissolve them.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.